Definition
Shellfish poisoning refers to a group of human illnesses caused by the consumption of marine or freshwater mollusks (such as mussels, clams, oysters, and scallops) that have accumulated natural toxins produced by certain microscopic algae. The condition is not caused by pathogenic microorganisms but by biotoxins that can affect the nervous system, gastrointestinal tract, or other organ systems.
Overview
During algal bloom events, species of dinoflagellates, diatoms, or cyanobacteria proliferate and synthesize potent toxins. Filter‑feeding mollusks ingest these microorganisms and concentrate the toxins in their tissues. Humans who eat contaminated shellfish may develop symptoms ranging from mild gastrointestinal distress to severe neurological impairment, depending on the toxin type and dose. The major clinical syndromes recognised worldwide are:
- Paralytic Shellfish Poisoning (PSP) – caused mainly by saxitoxin and its derivatives.
- Neurotoxic Shellfish Poisoning (NSP) – associated with brevetoxins.
- Diarrhetic Shellfish Poisoning (DSP) – linked to okadaic acid and related compounds.
- Amnesic Shellfish Poisoning (ASP) – resulting from domoic acid.
Incidence of shellfish poisoning fluctuates regionally, often correlating with seasonal algal blooms and water temperature. Public health agencies monitor toxin levels in harvested shellfish and may close affected fisheries to reduce risk.
Etymology/Origin
The term combines “shellfish,” denoting edible mollusks protected by a hard shell, with “poisoning,” indicating illness produced by a toxic substance. The phrase entered scientific literature in the mid‑20th century as research identified specific algal toxins responsible for the conditions.
Characteristics
| Aspect | Details |
|---|---|
| Causative agents | Biotoxins such as saxitoxin, brevetoxin, okadaic acid, domoic acid, produced by harmful algal species (e.g., Alexandrium spp., Karenia brevis, Dinophysis spp., Pseudo-nitzschia spp.). |
| Primary exposure route | Ingestion of raw, boiled, or otherwise prepared shellfish that contain toxin concentrations above regulatory limits. |
| Typical incubation period | Minutes to several hours after consumption, varying by toxin type. |
| Clinical manifestations |
|
| Diagnosis | Based on recent shellfish ingestion history, symptomatology, and laboratory confirmation of toxins in patient samples (blood, urine) or in the consumed shellfish. |
| Treatment | Mainly supportive: airway management for PSP/NSP, intravenous fluids for DSP, and seizure control for ASP. No specific antidotes are widely available; early medical care improves outcomes. |
| Prevention | Routine monitoring of toxin levels in commercial shellfish beds, closure of contaminated harvesting areas, public advisories, and proper cooking guidance (although many toxins are heat‑stable). |
| Regulatory limits | Many countries adopt the Codex Alimentarius standard of 80 µg saxitoxin equivalents per kilogram of shellfish meat for PSP; comparable limits exist for other toxins. |
Related Topics
- Harmful algal blooms (HABs)
- Marine biotoxins
- Food safety regulations (e.g., Codex Alimentarius, FDA’s Marine Biotoxin Program)
- Aquaculture and shellfish harvesting practices
- Public health surveillance of foodborne illnesses
- Neurotoxic, diarrhetic, amnesic, and paralytic poisoning syndromes
This entry reflects current, peer‑reviewed knowledge up to 2024. Any newly emerging data not yet incorporated into reputable scientific sources is not included.